Skip to content

To Study the effectiveness of Kunkumapoo Mathirai (Tablet) On Hyperhidrosis (Increased Sweating)

A Pilot Study Of The Safety And Effectiveness Of Kungumapoo Mathirai (A Siddha Herbo-mineral Formulation) In Subject With Hyperhidrosis (Athi Viyarvai) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058106
Enrollment
10
Registered
2023-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L745- Focal hyperhidrosis

Interventions

Intervention1: Kungumapoo Mathirai: Dose: 2 tablets. Frequency: Twice a day. Route Of administration: Internal Medicine with water. Duration: 48 days. Control Intervention1: NOT APPLICABLE: NOT APLICA

Sponsors

Dr Hitha Shyam M S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known case of Hyperhidrosis Patients having the symptoms of Focal Hyperhidrosis (Excessive sweating only in Armpits, hands, feet and head/face cause at least once in a week)

Exclusion criteria

Exclusion criteria: 1.Secondary Hyperhidrosis 2.Diabetes mellitus 3.Hypertension 4.Cardiac disease 5.Thyroid diseases 6.Pregnancy 7.Age above 50 8.Age below 12 9.Psychiatric patients 10.Epilepsy patients 11.Parkinsonism 12.Patients who take certain medications, such as pain relievers, antidepressants, and some diabetes and hormonal medications. 13.Menopause hot flashes 14.Thyroid problems 15.All types of cancer 16.Nervous system disorders 17.Infections.

Design outcomes

Primary

MeasureTime frame
Primary outcome is assessed by comparing the Hyperhidrosis Disease Severity Scale before & after treatment. Timepoint: 48 DAYS

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the answers of Quality of life assessment questionnaire. Timepoint: 48 DAYS

Countries

India

Contacts

Public ContactDr Hitha Shyam M S

National Institute Of Siddha

hithashyam1@gmail.com8610774064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026